F200A substitution in the third transmembrane helix of human cannabinoid CB1 receptor converts AM2233 from receptor agonist to inverse agonist (abst – 2006) http://www.ncbi.nlm.nih.gov/pubmed/16438957
Evaluation of the in vivo receptor occupancy for the behavioral effects of cannabinoids using a radiolabeled cannabinoid receptor agonist, R-[125/131I]AM2233 (abst – 2006) http://www.ncbi.nlm.nih.gov/pubmed/16715483
Another nail in coffin of synthetic cannabis (news – 2011) http://tvnz.co.nz/national-news/anot...666168?ref=rss
Characteristics of the designer drug and synthetic cannabinoid receptor agonist AM-2201 regarding its chemistry and metabolism (abst – 2013) http://www.ncbi.nlm.nih.gov/pubmed/23832945
Evaluation of the in vivo receptor occupancy for the behavioral effects of cannabinoids using a radiolabeled cannabinoid receptor agonist, R-[125/131I]AM2233 (abst – 2006) http://www.ncbi.nlm.nih.gov/pubmed/16715483
Another nail in coffin of synthetic cannabis (news – 2011) http://tvnz.co.nz/national-news/anot...666168?ref=rss
Characteristics of the designer drug and synthetic cannabinoid receptor agonist AM-2201 regarding its chemistry and metabolism (abst – 2013) http://www.ncbi.nlm.nih.gov/pubmed/23832945